John Tilton
2018
In 2018, John Tilton earned a total compensation of $1.5M as Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd..
Compensation breakdown
| Bonus | $162,225 |
|---|---|
| Option Awards | $1,035,600 |
| Salary | $309,000 |
| Other | $18,849 |
| Total | $1,525,674 |
Tilton received $1M in option awards, accounting for 68% of the total pay in 2018.
Tilton also received $162.2K in bonus, $309K in salary and $18.8K in other compensation.
Rankings
In 2018, John Tilton's compensation ranked 7,080th out of 14,244 executives tracked by ExecPay. In other words, Tilton earned more than 50.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,080 out of 14,244 | 50th |
Division Manufacturing | 2,720 out of 5,765 | 53rd |
Major group Chemicals And Allied Products | 1,024 out of 2,128 | 52nd |
Industry group Drugs | 863 out of 1,817 | 53rd |
Industry Pharmaceutical Preparations | 673 out of 1,391 | 52nd |
Source: SEC filing on April 11, 2019.
Tilton's colleagues
We found four more compensation records of executives who worked with John Tilton at Biohaven Pharmaceutical Holding Co Ltd. in 2018.
2018
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2018
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
2018
Charles Conway
Biohaven Pharmaceutical Holding Co Ltd.
Chief Scientific Officer
2018
Kimberly Gentile
Biohaven Pharmaceutical Holding Co Ltd.